| For: | Panasiuk A, Dzieciol J, Panasiuk B, Prokopowicz D. Expression of p53, Bax and Bcl-2 proteins in hepatocytes in non-alcoholic fatty liver disease. World J Gastroenterol 2006; 12(38): 6198-6202 [PMID: 17036395 DOI: 10.3748/wjg.v12.i38.6198] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v12/i38/6198.htm |
| Number | Citing Articles |
| 1 |
Bre-Anne Fifield, John Talia, Carlee Stoyanovich, Mitchell J Elliott, Martin K Bakht, Amy Basilious, Joshua P Samsoondar, Madison Curtis, Keith F Stringer, Lisa A Porter. Cyclin-like proteins tip regenerative balance in the liver to favour cancer formation. Carcinogenesis 2020; 41(6) doi: 10.1093/carcin/bgz164
|
| 2 |
Mengqing Wu, Yang Liu, Xiao Zhu, Xiaoke Zhang, Qinghong Kong, Wei Lu, Xiao Yuan, Yunlai Liu, Yang Liu, Keyu Lu, Yangxue Dai, Bo Zhang. Advances in i-motif structures: Stability, gene expression, and therapeutic applications. International Journal of Biological Macromolecules 2025; 311 doi: 10.1016/j.ijbiomac.2025.143555
|
| 3 |
Xi Jin, Jiang Liu, Yi-peng Chen, Zun Xiang, Jie-xia Ding, You-ming Li, Patricia Aspichueta. Effect of miR-146 targeted HDMCP up-regulation in the pathogenesis of nonalcoholic steatohepatitis. PLOS ONE 2017; 12(3) doi: 10.1371/journal.pone.0174218
|
| 4 |
Xiaoqing Luo, Jianye Zhang, Yue Gao, Weifei Pan, Yayuan Yang, Xu Li, Lingfei Chen, Chang Wang, Yuqing Wang. Emerging roles of i-motif in gene expression and disease treatment. Frontiers in Pharmacology 2023; 14 doi: 10.3389/fphar.2023.1136251
|
| 5 |
Aliaa Sabry, Hazem Zakaria, Doha Maher, Randa Mohamed Seddik, Ali Nada, Dirk Uhlmann. Ischemia–Reperfusion Injury at Time‐Zero Biopsy as a Prognostic Factor in Predicting Liver Graft Outcome in Egyptian Living Donor Liver Transplanted Patients. International Journal of Hepatology 2025; 2025(1) doi: 10.1155/ijh/9113107
|
| 6 |
Laila Naif Al-Harbi, Ghedeir M. Alshammari, Alhanouf Mohammed Al-Dossari, Pandurangan Subash-Babu, Manal Abdulaziz Binobead, Maha H. Alhussain, Sahar Abdulaziz AlSedairy, Doha M. Al-Nouri, Ghalia Shamlan. Beta vulgaris L. (Beetroot) Methanolic Extract Prevents Hepatic Steatosis and Liver Damage in T2DM Rats by Hypoglycemic, Insulin-Sensitizing, Antioxidant Effects, and Upregulation of PPARα. Biology 2021; 10(12) doi: 10.3390/biology10121306
|
| 7 |
Michael H. Miller, Michael A. J. Ferguson, John F. Dillon. Systematic review of performance of non-invasive biomarkers in the evaluation of non-alcoholic fatty liver disease. Liver International 2011; 31(4) doi: 10.1111/j.1478-3231.2011.02451.x
|
| 8 |
Wing-Kin Syn, Steve S. Choi, Anna Mae Diehl. Apoptosis and Cytokines in Non-Alcoholic Steatohepatitis. Clinics in Liver Disease 2009; 13(4) doi: 10.1016/j.cld.2009.07.003
|
| 9 |
Catherine Brenner, Lorenzo Galluzzi, Oliver Kepp, Guido Kroemer. Decoding cell death signals in liver inflammation. Journal of Hepatology 2013; 59(3) doi: 10.1016/j.jhep.2013.03.033
|
| 10 |
Qiushi Xu, Yunhui Fan, Juan J. Loor, Yusheng Liang, Hongming Lv, Xudong Sun, Hongdou Jia, Chuang Xu. Aloin protects mice from diet-induced non-alcoholic steatohepatitis via activation of Nrf2/HO-1 signaling. Food & Function 2021; 12(2) doi: 10.1039/D0FO02684K
|
| 11 |
Mathias Flensted-Jensen, Denise Oró, Emma A. Rørbeck, Chen Zhang, Martin Rønn Madsen, Andreas Nygaard Madsen, Jenny Norlin, Michael Feigh, Steen Larsen, Henrik H. Hansen. Dietary intervention reverses molecular markers of hepatocellular senescence in the GAN diet-induced obese and biopsy-confirmed mouse model of NASH. BMC Gastroenterology 2024; 24(1) doi: 10.1186/s12876-024-03141-x
|
| 12 |
Hanan El Bassat, Dina H. Ziada, Eiman A. Hasby, Hala Nagy, Mohammad H. Abo Ryia. Apoptotic and anti-apoptotic seromarkers for assessment of disease severity of non-alcoholic steatohepatitis. Arab Journal of Gastroenterology 2014; 15(1) doi: 10.1016/j.ajg.2014.01.009
|
| 13 |
Heechul Nam, Ji Lim, Tae Kim, Eun Kim, Sae-Jong Oum, Si Bae, Cheol Park. Extracellular Superoxide Dismutase Attenuates Hepatic Oxidative Stress in Nonalcoholic Fatty Liver Disease through the Adenosine Monophosphate-Activated Protein Kinase Activation. Antioxidants 2023; 12(12) doi: 10.3390/antiox12122040
|
| 14 |
Tianhua He, Nikita Lykov, Xu Luo, Huiling Wang, Zhanxiang Du, Ziyi Chen, Shitian Chen, Lin Zhu, Ye Zhao, Chimeng Tzeng. Protective Effects of Lactobacillus gasseri against High-Cholesterol Diet-Induced Fatty Liver and Regulation of Host Gene Expression Profiles. International Journal of Molecular Sciences 2023; 24(3) doi: 10.3390/ijms24032053
|
| 15 |
Marco Bertolotti, Amedeo Lonardo, Chiara Mussi, Enrica Baldelli, Elisa Pellegrini, Stefano Ballestri, Dante Romagnoli, Paola Loria. Nonalcoholic fatty liver disease and aging: Epidemiology to management. World Journal of Gastroenterology 2014; 20(39): 14185-14204 doi: 10.3748/wjg.v20.i39.14185
|
| 16 |
Cheng Chen, Xiao-cui Liu, Bin Deng. Protective Effects of Berberine on Nonalcoholic Fatty Liver Disease in db/db Mice via AMPK/SIRT1 Pathway Activation. Current Medical Science 2024; 44(5) doi: 10.1007/s11596-024-2914-y
|
| 17 |
Johanna Pedroza-Diaz, Johanna C. Arroyave-Ospina, Sandra Serna Salas, Han Moshage. Modulation of Oxidative Stress-Induced Senescence during Non-Alcoholic Fatty Liver Disease. Antioxidants 2022; 11(5) doi: 10.3390/antiox11050975
|
| 18 |
Tan Khanh Nguyen, Huy Hieu Phung, Won Jun Choi, Hee-Chul Ahn. Network Pharmacology and Molecular Docking Study on the Multi-Target Mechanisms of Aloe vera for Non-Alcoholic Steatohepatitis Treatment. Plants 2022; 11(24) doi: 10.3390/plants11243585
|
| 19 |
Chawon Yun, Sou Hyun Kim, Doyoung Kwon, Mi Ran Byun, Ki Wung Chung, Jaewon Lee, Young-Suk Jung. Doxorubicin Attenuates Free Fatty Acid-Induced Lipid Accumulation via Stimulation of p53 in HepG2 Cells. Biomolecules & Therapeutics 2024; 32(1) doi: 10.4062/biomolther.2023.200
|
| 20 |
Karen Louise Thomsen, Peter Lykke Eriksen, Annarein JC. Kerbert, Francesco De Chiara, Rajiv Jalan, Hendrik Vilstrup. Role of ammonia in NAFLD: An unusual suspect. JHEP Reports 2023; 5(7) doi: 10.1016/j.jhepr.2023.100780
|
| 21 |
Xutao Li, Tianyin Ruan, Siyuan Wang, Mingyue Li, Li Shen, Yuan Peng, Zhimin Zhao, Yang Lei, Yanyan Tao. Compound Dancao Granules inhibits lipid accumulation and hepatocyte apoptosis via the p53 signaling pathway in metabolic dysfunction-associated steatohepatitis mice. Journal of Ethnopharmacology 2026; 368 doi: 10.1016/j.jep.2026.121779
|
| 22 |
Wensheng Liu, Robert D. Baker, Tavleen Bhatia, Lixin Zhu, Susan S. Baker. Pathogenesis of nonalcoholic steatohepatitis. Cellular and Molecular Life Sciences 2016; 73(10) doi: 10.1007/s00018-016-2161-x
|
| 23 |
Xiaoya Li, Jing Wang, Xue Gong, Meiling Zhang, Shuangshuang Kang, Bing Shu, Zuzhuang Wei, Zhi-Shu Huang, Ding Li. Upregulation of BCL-2 by acridone derivative through gene promoter i-motif for alleviating liver damage of NAFLD/NASH. Nucleic Acids Research 2020; 48(15) doi: 10.1093/nar/gkaa615
|
| 24 |
Meital Charni, Noa Rivlin, Alina Molchadsky, Ronit Aloni-Grinstein, Varda Rotter. p53 in liver pathologies—taking the good with the bad. Journal of Molecular Medicine 2014; 92(12) doi: 10.1007/s00109-014-1223-5
|
| 25 |
Huiling Wu, Xi Song, Yuntao Ling, Jin Zhou, Zhen Tao, Yuying Shen. Comprehensive bioinformatics analysis of critical lncRNAs, mRNAs and miRNAs in non‑alcoholic fatty liver disease. Molecular Medicine Reports 2019; doi: 10.3892/mmr.2019.9931
|
| 26 |
Yanyong Xu, Yingdong Zhu, Shuwei Hu, Yang Xu, Diane Stroup, Xiaoli Pan, Fathima Cassim Bawa, Shaoru Chen, Raja Gopoju, Liya Yin, Yanqiao Zhang. Hepatocyte Nuclear Factor 4α Prevents the Steatosis‐to‐NASH Progression by Regulating p53 and Bile Acid Signaling (in mice). Hepatology 2021; 73(6) doi: 10.1002/hep.31604
|
| 27 |
Xuequn Zhang, Yiming Lin, Sisi Lin, Chunxiao Li, Jianguo Gao, Zemin Feng, Jinghua Wang, Jie Zhang, Hong Zhang, Yuwei Zhang, Xueyang Chen, Shenghui Chen, Chengfu Xu, Youming Li, Chaohui Yu, Hang Zeng. Silencing of functional p53 attenuates NAFLD by promoting HMGB1-related autophagy induction. Hepatology International 2020; 14(5) doi: 10.1007/s12072-020-10068-4
|
| 28 |
Shahar Azar, Shiran Udi, Adi Drori, Rivka Hadar, Alina Nemirovski, Kiran V. Vemuri, Maya Miller, Dana Sherill-Rofe, Yhara Arad, Devorah Gur-Wahnon, Xiaoling Li, Alexandros Makriyannis, Danny Ben-Zvi, Yuval Tabach, Iddo Z. Ben-Dov, Joseph Tam. Reversal of diet-induced hepatic steatosis by peripheral CB1 receptor blockade in mice is p53/miRNA-22/SIRT1/PPARα dependent. Molecular Metabolism 2020; 42 doi: 10.1016/j.molmet.2020.101087
|
| 29 |
Denada Dibra, Xueqing Xia, Abhisek Mitra, Jeffry J. Cutrera, Guillermina Lozano, Shulin Li. Mutant p53 in concert with an interleukin‐27 receptor alpha deficiency causes spontaneous liver inflammation, fibrosis, and steatosis in mice. Hepatology 2016; 63(3) doi: 10.1002/hep.28379
|
| 30 |
Basile Keshavjee, Valentine Lambelet, Hanna Coppola, David Viertl, John O. Prior, Laurent Kappeler, Jean-Baptiste Armengaud, Jean-Pierre Chouraqui, Hassib Chehade, Paul-Emmanuel Vanderriele, Manon Allouche, Anne Balsiger, Alexandre Sarre, Anne-Christine Peyter, Umberto Simeoni, Catherine Yzydorczyk. Stress-Induced Premature Senescence Related to Oxidative Stress in the Developmental Programming of Nonalcoholic Fatty Liver Disease in a Rat Model of Intrauterine Growth Restriction. Antioxidants 2022; 11(9) doi: 10.3390/antiox11091695
|
| 31 |
Chongyang Ma, Mengpei Zhao, Yuqiong Du, Shuang Jin, Xiaoyi Wu, Haiyan Zou, Qiuyun Zhang, Lianyin Gao, Chih-Yuan Ko. Network Pharmacology-Based Study on the Molecular Biological Mechanism of Action for Qingdu Decoction against Chronic Liver Injury. Evidence-Based Complementary and Alternative Medicine 2021; 2021 doi: 10.1155/2021/6661667
|
| 32 |
Christopher L. Gentile, Melinda A. Frye, Michael J. Pagliassotti. Fatty acids and the endoplasmic reticulum in nonalcoholic fatty liver disease. BioFactors 2011; 37(1) doi: 10.1002/biof.135
|
| 33 |
Zhibin Yan, Xiaokang Miao, Bangzhi Zhang, Junqiu Xie. p53 as a double-edged sword in the progression of non-alcoholic fatty liver disease. Life Sciences 2018; 215 doi: 10.1016/j.lfs.2018.10.051
|
| 34 |
Jelena Krstic, Markus Galhuber, Tim J. Schulz, Michael Schupp, Andreas Prokesch. p53 as a Dichotomous Regulator of Liver Disease: The Dose Makes the Medicine. International Journal of Molecular Sciences 2018; 19(3) doi: 10.3390/ijms19030921
|
| 35 |
Itziar Frades, Erik Andreasson, Jose Maria Mato, Erik Alexandersson, Rune Matthiesen, Mª Luz Martínez-Chantar, Matias A Avila. Integrative Genomic Signatures Of Hepatocellular Carcinoma Derived from Nonalcoholic Fatty Liver Disease. PLOS ONE 2015; 10(5) doi: 10.1371/journal.pone.0124544
|
| 36 |
Siyu Yu, Guang Ji, Li Zhang. The role of p53 in liver fibrosis. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.1057829
|
| 37 |
Clémence M. Canivet, Stéphanie Bonnafous, Déborah Rousseau, Pierre S. Leclere, Sandra Lacas-Gervais, Stéphanie Patouraux, Arnaud Sans, Carmelo Luci, Béatrice Bailly-Maitre, Antonio Iannelli, Albert Tran, Rodolphe Anty, Philippe Gual. Hepatic FNDC5 is a potential local protective factor against Non-Alcoholic Fatty Liver. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2020; 1866(5) doi: 10.1016/j.bbadis.2020.165705
|
| 38 |
Ali Mahmoudi, Mohammad Mahdi Hajihasani, Muhammed Majeed, Tannaz Jamialahmadi, Amirhossein Sahebkar. Effect of Calebin-A on Critical Genes Related to NAFLD: A
Protein-Protein Interaction Network and Molecular Docking Study. Current Genomics 2024; 25(2) doi: 10.2174/0113892029280454240214072212
|
| 39 |
Han Xue, Di Chen, Yan‐Ke Zhong, Zhen‐Diao Zhou, Shi‐Xin Fang, Ming‐Yao Li, Chuang Guo. Deferoxamine ameliorates hepatosteatosis via several mechanisms inob/obmice. Annals of the New York Academy of Sciences 2016; 1375(1) doi: 10.1111/nyas.13174
|
| 40 |
Nabil Mohie Abdel-Hamid, Ahmed Wahid, Maiiada Hassan Nazmy, Marwa Abdel-Moniem Eisa. Synergistic Effects of Jerusalem Artichoke in Combination with Pegylated Interferon Alfa-2a and Ribavirin Against Hepatic Fibrosis in Rats. Asian Pacific Journal of Cancer Prevention 2016; 17(4) doi: 10.7314/APJCP.2016.17.4.1979
|
| 41 |
Weigang Yuan, Mi Zhang, Chunxu Wang, Bin Li, Lei Li, Feng Ye, Chuanrui Xu. Resveratrol Attenuates High-Fat Diet–Induced Hepatic Lipotoxicity by Upregulating Bmi-1 Expression. The Journal of Pharmacology and Experimental Therapeutics 2022; 381(2) doi: 10.1124/jpet.121.001018
|
| 42 |
Jialing Wu, Chong Chen, Xi Hu, Xianbin Cai, Yinghong Guan, Hui Hu, Qinjia Wang, Xiaofeng Chen, Bozhi Cai, Xubin Jing. Suppressing Cyclooxygenase-2 Prevents nonalcoholic and inhibits apoptosis of hepatocytes that are involved in the Akt/p53 signal pathway. Biochemical and Biophysical Research Communications 2016; 469(4) doi: 10.1016/j.bbrc.2015.12.096
|
| 43 |
Shimaa Mohammad Yousof, Horeya Erfan, Marwa Mohamed Hosny, Shaimaa A. Shehata, Karima El-Sayed. Subacute toxic effects of silver nanoparticles oral administration and withdrawal on the structure and function of adult Albino Rats’ hepatic tissue. Saudi Journal of Biological Sciences 2022; 29(5) doi: 10.1016/j.sjbs.2022.02.054
|
| 44 |
Fatemeh Mirzaei, Ebrahim Abbasi, Amir Mirzaei, Nashmin Fayazi Hosseini, Nima Naseri, Iraj Khodadadi, Cyrus Jalili, Nesrine Majdoub. Toxicity and Hepatoprotective Effects of ZnO Nanoparticles on Normal and High-Fat Diet-Fed Rat Livers: Mechanism of Action. Biological Trace Element Research 2025; 203(1) doi: 10.1007/s12011-024-04108-5
|
| 45 |
Stefan H. Luijmes, Roberto Broere, Jeroen de Jonge. The Liver Graft Before Transplantation. 2024; doi: 10.1016/B978-0-323-99655-6.00005-1
|
| 46 |
Mario Arciello, Alessia Longo, Carmela Viscomi, Concetta Capo, Antonio Angeloni, Luisa Rossi, Clara Balsano. Core domain mutant Y220C of p53 protein has a key role in copper homeostasis in case of free fatty acids overload. BioMetals 2015; 28(6) doi: 10.1007/s10534-015-9886-0
|
| 47 |
Che-Pei Kung, Maureen E Murphy. The role of the p53 tumor suppressor in metabolism and diabetes. Journal of Endocrinology 2016; 231(2) doi: 10.1530/JOE-16-0324
|
| 48 |
Wenhua Wang, Xia Liu, Hengqi Liu, Hassan Abolhassani, Han Yan, Huilai Zhang, Xianhuo Wang. p53: from understanding its structure to advances in therapeutic targeting. Signal Transduction and Targeted Therapy 2026; 11(1) doi: 10.1038/s41392-025-02549-5
|
| 49 |
Rania Abdel Rahman Elgawish, Haidy G. Abdel Rahman, Heba M.A. Abdelrazek. Green tea extract attenuates CCl4-induced hepatic injury in male hamsters via inhibition of lipid peroxidation and p53-mediated apoptosis. Toxicology Reports 2015; 2 doi: 10.1016/j.toxrep.2015.08.001
|
| 50 |
Arash Kheradmand, Omid Dezfoulian, Mohammad Javad Tarrahi. Ghrelin attenuates heat-induced degenerative effects in the rat testis. Regulatory Peptides 2011; 167(1) doi: 10.1016/j.regpep.2010.12.002
|
| 51 |
G. Song, H. Vollbrecht. Translating MicroRNAs to the Clinic. 2017; doi: 10.1016/B978-0-12-800553-8.00005-6
|
| 52 |
|
| 53 |
Shakir D. AlSharari, Salim S. Al-Rejaie, Hatem M. Abuohashish, Mohamed M. Ahmed, Mohamed M. Hafez, Reiko Matsui. Rutin Attenuates Hepatotoxicity in High‐Cholesterol‐Diet‐Fed Rats. Oxidative Medicine and Cellular Longevity 2016; 2016(1) doi: 10.1155/2016/5436745
|
| 54 |
Kai Liu, Jinli Lou, Tao Wen, Jiming Yin, Bin Xu, Wei Ding, Anna Wang, Daojie Liu, Chao Zhang, Dexi Chen, Ning Li. Depending on the stage of hepatosteatosis, p53 causes apoptosis primarily through either DRAM‐induced autophagy or BAX. Liver International 2013; 33(10) doi: 10.1111/liv.12238
|
| 55 |
Atilla Engin. Obesity and Lipotoxicity. Advances in Experimental Medicine and Biology 2017; 960 doi: 10.1007/978-3-319-48382-5_19
|
| 56 |
Geoffrey C Farrell, Claire Z Larter, Jing Yun Hou, Rena H Zhang, Matthew M Yeh, Jacqueline Williams, Aileen Dela Peňa, Rona Francisco, Sarah R Osvath, John Brooling, Narcissus Teoh, Lisa M Sedger. Apoptosis in experimental NASH is associated with p53 activation and TRAIL receptor expression. Journal of Gastroenterology and Hepatology 2009; 24(3) doi: 10.1111/j.1440-1746.2009.05785.x
|
| 57 |
Wenjun Lin, Xin Zhang, Chuan Zhang, Li Li, Jing Zhang, Ping Xie, Yutao Zhan, Wei An. Deletion of Smurf1 attenuates liver steatosis via stabilization of p53. Laboratory Investigation 2022; 102(10) doi: 10.1038/s41374-022-00802-x
|
| 58 |
Sevil A. Grabeklis, Liudmila M. Mikhaleva, Maria A. Kozlova, David A. Areshidze, Alexander M. Dygai. Influence of constant lighting on the morphofunctional state and rhythmostasis of the liver of rats. Medical academic journal 2023; 23(2) doi: 10.17816/MAJ322855
|
| 59 |
Cornelius Engelmann, Frank Tacke. The Potential Role of Cellular Senescence in Non-Alcoholic Fatty Liver Disease. International Journal of Molecular Sciences 2022; 23(2) doi: 10.3390/ijms23020652
|
| 60 |
Yiran Liu, Mingyu Zhang, Yujie Huang, Yu Zhang, Chen Zhu, Jialun Guan, Suhong Xia, Jiazhi Liao. Involvement of ferroptosis in metabolic dysfunction-associated steatohepatitis-related liver diseases. Journal of Molecular Medicine 2025; 103(11-12) doi: 10.1007/s00109-025-02599-w
|
| 61 |
Yuxiang Song, Xinwei Li, Yu Li, Na Li, Xiaoxia Shi, Hongyan Ding, Yuhang Zhang, Xiaobing Li, Guowen Liu, Zhe Wang. Non-esterified fatty acids activate the ROS–p38–p53/Nrf2 signaling pathway to induce bovine hepatocyte apoptosis in vitro. Apoptosis 2014; 19(6) doi: 10.1007/s10495-014-0982-3
|
| 62 |
|
| 63 |
Kengo Tomita, Toshiaki Teratani, Takahiro Suzuki, Tetsuya Oshikawa, Hirokazu Yokoyama, Katsuyoshi Shimamura, Kiyoshi Nishiyama, Norikazu Mataki, Rie Irie, Tohru Minamino, Yoshikiyo Okada, Chie Kurihara, Hirotoshi Ebinuma, Hidetsugu Saito, Ippei Shimizu, Yohko Yoshida, Ryota Hokari, Kazuo Sugiyama, Kazuo Hatsuse, Junji Yamamoto, Takanori Kanai, Soichiro Miura, Toshifumi Hibi. p53/p66Shc-mediated signaling contributes to the progression of non-alcoholic steatohepatitis in humans and mice. Journal of Hepatology 2012; 57(4) doi: 10.1016/j.jhep.2012.05.013
|
| 64 |
Elisa Melucci, Maurizio Cosimelli, Livio Carpanese, Giuseppe Pizzi, Francesco Izzo, Francesco Fiore, Rita Golfieri, Emanuela Giampalma, Isabella Sperduti, Cristiana Ercolani, Rosa Sciuto, Raffaello Mancini, Carlo Garufi, Maria Grazia Diodoro, Marcella Mottolese. Decrease of survivin, p53 and Bcl-2 expression in chemorefractory colorectal liver metastases may be predictive of radiosensivity after radioembolization with yttrium-90 resin microspheres. Journal of Experimental & Clinical Cancer Research 2013; 32(1) doi: 10.1186/1756-9966-32-13
|
| 65 |
Robert Vincent, Arun Sanyal. Recent Advances in Understanding of NASH: MicroRNAs as Both Biochemical Markers and Players. Current Pathobiology Reports 2014; 2(3) doi: 10.1007/s40139-014-0049-8
|
| 66 |
David Ibarra Martínez, Israel Alejandro Muñoz Nieto, David Alejandro Hernández Marín, Javier Ventura Juárez, Sandra Luz Martínez Hernández, Esperanza Sánchez Alemán, Raquel Guerrero Alba, Martín Muñoz Ortega. ACC-1 as a Possible Biochemical Indicator of Lipoapoptosis in In Vivo and In Vitro Models of MAFLD. International Journal of Molecular Sciences 2025; 26(8) doi: 10.3390/ijms26083459
|
| 67 |
Mariana Verdelho Machado, Helena Cortez-Pinto. Cell death and nonalcoholic steatohepatitis: where is ballooning relevant?. Expert Review of Gastroenterology & Hepatology 2011; 5(2) doi: 10.1586/egh.11.16
|
| 68 |
Óscar Osorio-Conles, Arturo Vega-Beyhart, Ainitze Ibarzabal, José María Balibrea, Isabel Graupera, Jordi Rimola, Josep Vidal, Ana de Hollanda. A Distinctive NAFLD Signature in Adipose Tissue from Women with Severe Obesity. International Journal of Molecular Sciences 2021; 22(19) doi: 10.3390/ijms221910541
|
| 69 |
Sherif Mohamed Zaki, Dania S. Waggas. Protective Effect of Nigella sativa and Onion Extract against 5-Fluorouracil-Induced Hepatic Toxicity. Nutrition and Cancer 2022; 74(7) doi: 10.1080/01635581.2021.2019794
|
| 70 |
Justyna Strycharz, Jozef Drzewoski, Janusz Szemraj, Agnieszka Sliwinska, Miguel Constância. Is p53 Involved in Tissue‐Specific Insulin Resistance Formation?. Oxidative Medicine and Cellular Longevity 2017; 2017(1) doi: 10.1155/2017/9270549
|
| 71 |
Matthieu Lacroix, Romain Riscal, Giuseppe Arena, Laetitia Karine Linares, Laurent Le Cam. Metabolic functions of the tumor suppressor p53: Implications in normal physiology, metabolic disorders, and cancer. Molecular Metabolism 2020; 33 doi: 10.1016/j.molmet.2019.10.002
|
| 72 |
Vlasta Demeckova, Dagmar Mudronova, Sona Gancarcikova, Peter Kubatka, Karol Kajo, Monika Kassayova, Bianka Bojkova, Marian Adamkov, Peter Solár. 5-Fluorouracil Treatment of CT26 Colon Cancer Is Compromised by Combined Therapy with IMMODIN. International Journal of Molecular Sciences 2022; 23(12) doi: 10.3390/ijms23126374
|
| 73 |
Celeste K. Carberry, Angie L. Mordant, Christine A. Mills, Hadley Hartwell, Victoria F. Carberry, Lauren Simendinger, Elise Hickman, Laura E. Herring, Julia E. Rager, Daniel X Zhang. Functional effects of extracellular vesicles altered by a per- and polyfluoroalkyl substance mixture: In vitro liver cytotoxicity and proteomic expression alterations. PLOS One 2026; 21(3) doi: 10.1371/journal.pone.0338102
|
| 74 |
Xiaoli Pan, Yanqiao Zhang. Hepatocyte nuclear factor 4α in the pathogenesis of non-alcoholic fatty liver disease. Chinese Medical Journal 2022; 135(10) doi: 10.1097/CM9.0000000000002092
|
| 75 |
Elisabeth Rohbeck, Corinna Niersmann, Karl Köhrer, Thorsten Wachtmeister, Michael Roden, Jürgen Eckel, Tania Romacho. Positive allosteric GABAA receptor modulation counteracts lipotoxicity-induced gene expression changes in hepatocytes in vitro. Frontiers in Physiology 2023; 14 doi: 10.3389/fphys.2023.1106075
|
| 76 |
Lijun Pang, Kai Liu, Daojie Liu, Fudong Lv, Yunjin Zang, Fang Xie, Jiming Yin, Ying Shi, Yanjun Wang, Dexi Chen. Differential effects of reticulophagy and mitophagy on nonalcoholic fatty liver disease. Cell Death & Disease 2018; 9(2) doi: 10.1038/s41419-017-0136-y
|
| 77 |
Zohreh Khajehahmadi, Heidar Tavilani, Jamshid Karimi, Mohammad Rafiee, Zahra Arab-Sadeghabadi, Roohollah Mohseni, Sina Mohagheghi. Non-Alcoholic Steatohepatitis and Autoimmune Hepatitis Cirrhosis May Have a Higher Risk of Progression to Hepatocellular Carcinoma. Hepatitis Monthly 2023; (In Press) doi: 10.5812/hepatmon-138449
|
| 78 |
Lijuan Xue, Keanqi Liu, Caixia Yan, Junling Dun, Yexin Xu, Linlin Wu, Huizhu Yang, Huafang Liu, Lin Xie, Guangji Wang, Yan Liang. Schisandra lignans ameliorate nonalcoholic steatohepatitis by regulating aberrant metabolism of phosphatidylethanolamines. Acta Pharmaceutica Sinica B 2023; 13(8) doi: 10.1016/j.apsb.2023.04.009
|
| 79 |
Sarah M. Alsuliam, Nawal A. Albadr, Salah A. Almaiman, Abdullrahman S. Al-Khalifah, Noorah S. Alkhaldy, Ghedeir M. Alshammari. Fenugreek Seed Galactomannan Aqueous and Extract Protects against Diabetic Nephropathy and Liver Damage by Targeting NF-κB and Keap1/Nrf2 Axis. Toxics 2022; 10(7) doi: 10.3390/toxics10070362
|
| 80 |
Tian Cai, Ziyue Zhuang, Yuankai Wang, Jianquan Kan, Zsolt Zalán, Kewei Chen. Subchronic hepatorenal toxicity induced by low-dose neonicotinoid pesticide imidaclothiz exposure in mice. Pesticide Biochemistry and Physiology 2026; 216 doi: 10.1016/j.pestbp.2025.106786
|
| 81 |
Rui E. Castro, Duarte M.S. Ferreira, Marta B. Afonso, Pedro M. Borralho, Mariana V. Machado, Helena Cortez-Pinto, Cecília M.P. Rodrigues. miR-34a/SIRT1/p53 is suppressed by ursodeoxycholic acid in the rat liver and activated by disease severity in human non-alcoholic fatty liver disease. Journal of Hepatology 2013; 58(1) doi: 10.1016/j.jhep.2012.08.008
|
| 82 |
Kinya Okamoto, Masahiko Koda, Toshiaki Okamoto, Takumi Onoyama, Kenichi Miyoshi, Manabu Kishina, Tomomitsu Matono, Jun Kato, Shiho Tokunaga, Takaaki Sugihara, Akira Hiramatsu, Hideyuki Hyogo, Hiroshi Tobita, Shuichi Sato, Miwa Kawanaka, Yuichi Hara, Keisuke Hino, Kazuaki Chayama, Yoshikazu Murawaki, Hajime Isomoto, Catherine Mounier. Serum miR-379 expression is related to the development and progression of hypercholesterolemia in non-alcoholic fatty liver disease. PLOS ONE 2020; 15(2) doi: 10.1371/journal.pone.0219412
|
| 83 |
Maria Jimena Amaya, Michael H. Nathanson. Calcium Signaling in the Liver. Comprehensive Physiology 2013; 3(1) doi: 10.1002/j.2040-4603.2013.tb00492.x
|
| 84 |
Anil C. Anand, Subrat K. Acharya. The Story of Ammonia in Liver Disease: An Unraveling Continuum. Journal of Clinical and Experimental Hepatology 2024; 14(4) doi: 10.1016/j.jceh.2024.101361
|
| 85 |
Heng Wu, Raymond Ng, Xin Chen, Clifford J Steer, Guisheng Song. MicroRNA-21 is a potential link between non-alcoholic fatty liver disease and hepatocellular carcinoma via modulation of the HBP1-p53-Srebp1c pathway. Gut 2016; 65(11) doi: 10.1136/gutjnl-2014-308430
|
| 86 |
Zoltan Derdak, Kristine A. Villegas, Ragheb Harb, Annie M. Wu, Aryanna Sousa, Jack R. Wands. Inhibition of p53 attenuates steatosis and liver injury in a mouse model of non-alcoholic fatty liver disease. Journal of Hepatology 2013; 58(4) doi: 10.1016/j.jhep.2012.11.042
|
| 87 |
Toshihiro Goto, Michiko Itoh, Takayoshi Suganami, Sayaka Kanai, Ibuki Shirakawa, Takeru Sakai, Masahiro Asakawa, Toshihiro Yoneyama, Toshihiro Kai, Yoshihiro Ogawa. Obeticholic acid protects against hepatocyte death and liver fibrosis in a murine model of nonalcoholic steatohepatitis. Scientific Reports 2018; 8(1) doi: 10.1038/s41598-018-26383-8
|
| 88 |
Atilla Engin. Obesity and Lipotoxicity. Advances in Experimental Medicine and Biology 2024; 1460 doi: 10.1007/978-3-031-63657-8_18
|
| 89 |
Huanyu Lu, Linni Fan, Wenli Zhang, Guo Chen, An Xiang, Li Wang, Zifan Lu, Yue Zhai. The mitochondrial genome-encoded peptide MOTS-c interacts with Bcl-2 to alleviate nonalcoholic steatohepatitis progression. Cell Reports 2024; 43(1) doi: 10.1016/j.celrep.2023.113587
|
| 90 |
Tasmina Kanwal, Salim Saifullah, Talat Roome, Amtul Sami, Shazmeen Aslam, Shahida Muhammad Habib, Khadija Rehman, Anam Razzak, Faisal Shahab, Muhammad Raza Shah. Design and Development of Biotinylated SNEDDS for Improved Efficacy of Curcumin against Hepatocellular Carcinoma. Journal of Cluster Science 2025; 36(2) doi: 10.1007/s10876-025-02782-6
|
| 91 |
Takahiro Kodama, Tetsuo Takehara, Hayato Hikita, Satoshi Shimizu, Minoru Shigekawa, Hinako Tsunematsu, Wei Li, Takuya Miyagi, Atsushi Hosui, Tomohide Tatsumi, Hisashi Ishida, Tatsuya Kanto, Naoki Hiramatsu, Satoshi Kubota, Masaharu Takigawa, Yoshito Tomimaru, Akira Tomokuni, Hiroaki Nagano, Yuichiro Doki, Masaki Mori, Norio Hayashi. Increases in p53 expression induce CTGF synthesis by mouse and human hepatocytes and result in liver fibrosis in mice. Journal of Clinical Investigation 2011; 121(8) doi: 10.1172/JCI44957
|
| 92 |
Jozaa Z. ALTamimi, Ghedeir M. Alshammari, Nora A. AlFaris, Reham I. Alagal, Dalal H. Aljabryn, Norah A. Albekairi, Mahmoud Ahmad Alkhateeb, Mohammed Abdo Yahya. Ellagic acid protects against non-alcoholic fatty liver disease in streptozotocin-diabetic rats by activating AMPK. Pharmaceutical Biology 2022; 60(1) doi: 10.1080/13880209.2021.1990969
|
| 93 |
Eman A. Abd Elmaogod, Azza Hegazy, Abla S. Mahmoud, Ibrahim Marwan, Osama Hegazy, Mohamed El-Abgeegy, Heba F. Elsergany, Eman I. El-Desoki Mahmoud, Amal A. Mohamed, Hossam E.M. Soliman, Mohamed I. Seleem, Shawkat S. Gerges, Ahmed Albotaly, Ahmed Hamdy, Heba Abdelaziz, Amr Abdelraouf. Clinicopathological analysis of ischemia/reperfusion time-zero injury biopsies and its role in early allograft dysfunction in hepatic transplantation (retrospective cross-sectional study). Egyptian Journal of Pathology 2022; 42(2) doi: 10.4103/egjp.egjp_14_22
|
| 94 |
Ying Wan, Tianhao Zhou, Elise Slevin, Sachiko Koyama, Xuedong Li, Kelly Harrison, Tian Li, Bingru Zhou, Sugeily Ramos Lorenzo, Yudian Zhang, Wenjuan Xu, James E. Klaunig, Chaodong Wu, Ashok K. Shetty, Chiung‐Kuei Huang, Fanyin Meng. Liver‐specific deletion of microRNA‐34a alleviates ductular reaction and liver fibrosis during experimental cholestasis. The FASEB Journal 2023; 37(2) doi: 10.1096/fj.202201453R
|
| 95 |
Hiroya Yamada, Koji Suzuki, Naohiro Ichino, Yoshitaka Ando, Akira Sawada, Keisuke Osakabe, Keiko Sugimoto, Koji Ohashi, Ryouji Teradaira, Takashi Inoue, Nobuyuki Hamajima, Shuji Hashimoto. Associations between circulating microRNAs (miR-21, miR-34a, miR-122 and miR-451) and non-alcoholic fatty liver. Clinica Chimica Acta 2013; 424 doi: 10.1016/j.cca.2013.05.021
|
| 96 |
Pengzu Wang, Zhuang Lu, Meng He, Baoming Shi, Xingen Lei, Anshan Shan. The Effects of Endoplasmic-Reticulum-Resident Selenoproteins in a Nonalcoholic Fatty Liver Disease Pig Model Induced by a High-Fat Diet. Nutrients 2020; 12(3) doi: 10.3390/nu12030692
|
| 97 |
Leila Kheirandish-Gozal, Oscar Sans Capdevila, Ebrahim Kheirandish, David Gozal. Elevated Serum Aminotransferase Levels in Children at Risk for Obstructive Sleep Apnea. Chest 2008; 133(1) doi: 10.1378/chest.07-0773
|
| 98 |
Madushika M. Wimalarathne, Quiana C. Wilkerson-Vidal, Emily C. Hunt, Sharifa T. Love-Rutledge. The case for FAT10 as a novel target in fatty liver diseases. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.972320
|
| 99 |
Mohammad Reza Alipour, Roya Naderi, Alireza Alihemmati, Roghayeh Sheervalilou, Rafighe Ghiasi. Swimming training attenuates pancreatic apoptosis through miR-34a/Sirtu in1/P53 Axis in high-fat diet and Streptozotocin-induced Type-2 diabetic rats. Journal of Diabetes & Metabolic Disorders 2020; 19(2) doi: 10.1007/s40200-020-00670-6
|
| 100 |
Sarah Zakaria, Rehab A. Hasan, Mona F. Mahmoud, Hassan M. El Fayoumi, Amr A. A. Mahmoud. The concurrent exposure to aluminium and fructose induces liver injury in rats: Protection by monoammonium glycyrrhizinate. Clinical and Experimental Pharmacology and Physiology 2020; 47(5) doi: 10.1111/1440-1681.13257
|
| 101 |
Fatma Sayed Abdel-Aal Farag, Hend Mohamed Anwar, Tarek Aboushousha, Hala Sh. Mohammed, Lotfi Diab Mousa Ismail. Ameliorative Effects of Thunbergia erecta L. Leaves Against the Initiation of Hepatocarcinogenesis Induced by Diethylnitrosamine in the Rat Model. Applied Biochemistry and Biotechnology 2023; 195(10) doi: 10.1007/s12010-022-04292-x
|
| 102 |
David A. Areshidze, Maria A. Kozlova. Morphofunctional State and Circadian Rhythms of the Liver of Female Rats under the Influence of Chronic Alcohol Intoxication and Constant Lighting. International Journal of Molecular Sciences 2022; 23(18) doi: 10.3390/ijms231810744
|